Marked hypocalcemia after tocolytic magnesium sulphate therapy
- PMID: 17853341
- DOI: 10.1055/s-2007-986696
Marked hypocalcemia after tocolytic magnesium sulphate therapy
Abstract
Symptomatic hypocalcemia has been reported infrequently in association with magnesium sulfate (MgSO (4)) tocolytic therapy. We report a 38-year-old woman who presented in preterm labor at 24 3/7 weeks. Twenty hours after starting MgSO (4), she developed chest pain. Studies revealed therapeutic serum Mg level, total serum calcium (Ca) = 5.5 mg/dL, 24-hour urine Ca = 763.9 mg, and low serum uric acid and phosphate levels. All studies corrected day 1 postpartum; urine Ca level corrected on day 2. Even short courses of MgSO (4) can result in severe hypocalcemia, raising the question of whether Ca levels should be routinely monitored.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
